UGA Researchers Break Ground on Flu Vaccine

Researchers at the University of Georgia and Sanofi Pasteur, a multinational pharmaceutical company announced today the development of a vaccine that protects against multiple strains of both seasonal and pandemic H1N1 influenza in mouse models.

Using a technique called Computationally Optimized Broadly Reactive Antigen, UGA researchers Donald Carter, Christopher Darby and Bradford Lefoley created nine prototype synthetic compound vaccines constructed using genetic sequences from multiple influenza virus strains.

Sanofi Pasteur and UGA researchers are set to present their data tomorrow, March 30, at the World Vaccine Congress located in Washington, D.C.

Tags:

You May Also Like

UGA Talks about Mental Illness

Mental illness can be seen as a taboo subject, but not today. There will ...

UGA Catholic Center Opposes Religious Freedom Bill

The leadership of the UGA Catholic Center is opposing the Religious Freedom Bill. They ...

New UGA Veterinary Facility Dedicated Tomorrow

ATHENS, GA - The UGA College of Veterinary Medicine will celebrate the opening of ...